Breast cancer
UPDATED --- Systemic therapy for HER2-positive early breast cancer

Barbara (68 years old)

Barbara is a 68-year-old retired high school teacher who loves to go for long hikes in her newly gained free time. Unfortunately, she was diagnosed with HER2-positive breast cancer.

Assessment summary

  • Postmenopausal
  • Medical history: surgical repair torn cruciate ligament
  • ECOG PS: 0
  • Initial tumour size: cT2 (38 mm), initial lymph node status: cN1
  • Tumour biology: ER 0%, PgR 0%, HER2 IHC 3+, G3
  • CT scan chest/abdomen and bone scan: no metastases
  • Neoadjuvant therapy: anthracycline/taxane + trastuzumab + pertuzumab
  • Surgical therapy: breast conserving surgery and SLNB
    • Pathology report: residual invasive disease: ypT1c (12 mm), ypN0 (0/3 sn)
  • Adjuvant therapy: regimen of anti-HER2 therapy + radiation therapy

Which option would you choose for this patient?